Literature DB >> 16367947

Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics.

V Quaedvlieg1, M Henket, J Sele, R Louis.   

Abstract

The inflammatory pathways involved in asthma are more complex than the sole Th2-mediated eosinophilic airway inflammation. Different phenotypes of asthma have been recently highlighted and are probably underlied by different immunological profiles. The aim of the study was to assess cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Induced sputum was obtained from 48 consecutive stable mild to moderate asthmatics (20 eosinophilic asthmatics, 28 non-eosinophilic asthmatics) and 31 healthy subjects. Cytokine released from sputum cells were measured by a home-made two-step sandwich immunoassay. Cytokines investigated were interleukin (IL)-4, IL-6, IL-10, tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma. Sputum cells from eosinophilic asthmatics produced more IL-4 than those from both healthy subjects (P < 0.05) and non-eosinophilic asthmatics (P < 0.05). Conversely, sputum cells from eosinophilic asthma were found to release lower amounts of TNF-alpha than those from healthy subjects (P < 0.05). The group of non-eosinophilic asthmatics did not distinguish from healthy subjects with respect to any cytokines measured. Sputum cells from asthmatics exhibiting eosinophilic airway inflammation release more IL-4 and less TNF-alpha than those of healthy subjects. By contrast, non-eosinophilic asthmatics did not distinguish from healthy subjects by abnormal cytokine release from their sputum cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16367947      PMCID: PMC1809571          DOI: 10.1111/j.1365-2249.2005.02968.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma.

Authors:  M Delvaux; M Henket; L Lau; P Kange; P Bartsch; R Djukanovic; R Louis
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 2.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

3.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Authors:  Ruth H Green; Christopher E Brightling; Susan McKenna; Beverley Hargadon; Debbie Parker; Peter Bradding; Andrew J Wardlaw; Ian D Pavord
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

4.  Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics.

Authors:  G M Möller; T A de Jong; T H van der Kwast; S E Overbeek; A F Wierenga-Wolf; T Thepen; H C Hoogsteden
Journal:  Am J Respir Cell Mol Biol       Date:  1996-05       Impact factor: 6.914

Review 5.  Interleukin-6 family of cytokines and gp130.

Authors:  T Kishimoto; S Akira; M Narazaki; T Taga
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

Review 6.  The importance of Th2-like cells in the pathogenesis of airway allergic inflammation.

Authors:  M Ricci; O Rossi; M Bertoni; A Matucci
Journal:  Clin Exp Allergy       Date:  1993-05       Impact factor: 5.018

7.  Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1.

Authors:  S Sone; H Yanagawa; Y Nishioka; E Orino; G Bhaskaran; A Nii; K Mizuno; Y Heike; F Ogushi; T Ogura
Journal:  Eur Respir J       Date:  1992-02       Impact factor: 16.671

Review 8.  Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)

Authors:  R N Maini; M J Elliott; F M Brennan; M Feldmann
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product.

Authors:  R Moqbel; S Ying; J Barkans; T M Newman; P Kimmitt; M Wakelin; L Taborda-Barata; Q Meng; C J Corrigan; S R Durham; A B Kay
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

10.  Circulating interleukin-6 levels in patients with bronchial asthma.

Authors:  A Yokoyama; N Kohno; S Fujino; H Hamada; Y Inoue; S Fujioka; S Ishida; K Hiwada
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

View more
  4 in total

1.  Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients.

Authors:  Changchun Hou; Hou Changchun; Haijin Zhao; Zhao Haijin; Wenjun Li; Li Wenjun; Zhenyu Liang; Liang Zhenyu; Dan Zhang; Zhang Dan; Laiyu Liu; Liu Laiyu; Wancheng Tong; Tong Wancheng; Shao-Xi Cai; Cai Shao-Xi; Fei Zou; Zou Fei
Journal:  Cell Stress Chaperones       Date:  2011-06-04       Impact factor: 3.667

2.  High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.

Authors:  Changchun Hou; Haijin Zhao; Laiyu Liu; Wenjun Li; Xiaoting Zhou; Yanhua Lv; Xiangbo Shen; Zhenyu Liang; Shaoxi Cai; Fei Zou
Journal:  Mol Med       Date:  2011-03-03       Impact factor: 6.354

3.  Traffic-related particulate matter and acute respiratory symptoms among New York City area adolescents.

Authors:  Molini M Patel; Steven N Chillrud; Juan C Correa; Yair Hazi; Marian Feinberg; Deepti Kc; Swati Prakash; James M Ross; Diane Levy; Patrick L Kinney
Journal:  Environ Health Perspect       Date:  2010-05-07       Impact factor: 9.031

4.  Markers of respiratory inflammation in horses in relation to seasonal changes in air quality in a conventional racing stable.

Authors:  Miia Riihimäki; Amanda Raine; Lena Elfman; John Pringle
Journal:  Can J Vet Res       Date:  2008-10       Impact factor: 1.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.